Skip to Navigation Skip to Search Skip to Content
Search All Centers

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a type of cancer that begins in your bone marrow, where all blood cells are formed. The disease is called “acute” because of its aggressive nature, and “myeloid” because it affects the myeloid cells, which develop into red blood cells, white blood cells or platelets. You may have also heard AML referred to as acute myelocytic leukemia, acute myelogenous leukemia, acute granulocytic leukemia or acute non-lymphocytic leukemia, as the disease has several names.

There are many effective treatments available for AML, including chemotherapy, targeted therapy, drug therapy and bone marrow transplants. In addition, there is ongoing research leading to promising new therapies. This has led to the ability to treat specific subtypes of AML with tailored treatments. Researchers are also on the path to discovering how different gene mutations lead to specific forms of the disease. There are many innovative treatment options for acute myeloid leukemia, with more on the way from dedicated doctors, experts and researchers.

To learn more about acute myeloid leukemia, navigate to "What is AML?"

Latest News